Home › Germ Cell and Embryonal Cancer › Indiana › Indianapolis
Germ Cell and Embryonal Cancer clinical trials in Indianapolis, IN
4 studies for Germ Cell and Embryonal Cancer are looking for participants at sites in and around Indianapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
RecruitingPhase 3
- Riley Hospital for Children, Indianapolis
- Ascension Saint Vincent Indianapolis Hospital, Indianapolis
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
RecruitingPhase 1
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT
RecruitingPhase 2
- Indiana University Melvin & Bren Simon Cancer Center, Indianapolis
Maintenance Zanzalintinib With Etoposide After HDCT in GCT
RecruitingPhase 1/2
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Germ Cell and Embryonal Cancer trials in other cities
- Houston, TX6 studies
- Columbus, OH5 studies
- New York City, NY5 studies
- Chicago, IL4 studies
- St. Louis, MO4 studies
- Memphis, TN3 studies
- Boston, MA3 studies
- Dallas, TX3 studies
- Winston-Salem, NC3 studies
- Greenburgh, NY3 studies
- San Antonio, TX3 studies
- Clifton, NJ3 studies
Other studies in Indianapolis
- Non-Small Cell Lung Cancer32 studies
- Cancer (all types)24 studies
- Heart Failure23 studies
- Obesity20 studies
- Breast Cancer20 studies
- Metastatic Cancer19 studies
- Colorectal Cancer18 studies
- Ovarian Cancer17 studies
- Cardiovascular Disease17 studies
- Lung Cancer16 studies
- Type 1 Diabetes14 studies
- Endometrial Cancer14 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.